Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Exploring Cinnarizine's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
3 October 2023
This article summarized the latest R&D progress of Cinnarizine, the Mechanism of Action for Cinnarizine, and the drug target R&D trends for Cinnarizine.
Valuable Targets
5 min read
Advances in Clinical Research on SOS1 inhibitors
3 October 2023
SOS1, is a protein that plays a crucial role in signal transduction pathways within the human body.
Latest Hotspot
3 min read
Roivant Reports Encouraging Preliminary Results for Phase 1 SAD and 300mg Under-skin IMVT-1402 MAD Trials
3 October 2023
Immunovant, Inc. recently revealed preliminary results of a Phase 1 clinical trial for IMVT-1402.
Drug Insights
4 min read
Decoding Carfilzomib: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
3 October 2023
This article summarized the latest R&D progress of Carfilzomib, the Mechanism of Action for Carfilzomib, and the drug target R&D trends for Carfilzomib.
Latest Hotspot
3 min read
Nippon Kayaku and Celltrion declared the Japanese market's endorsement of Adalimumab Biosimilar Monoclonal Antibody
3 October 2023
Nippon Kayaku Co., Ltd. and Celltrion Healthcare Japan K.K. have gained approval to manufacture and sell various Adalimumab BS Subcutaneous Injections and Pens in Japan.
Valuable Targets
5 min read
Broad-spectrum anti-cancer drugs - RET inhibitors
3 October 2023
RET is a proto-oncogene initially discovered in 1985, it is located on chromosome 10q11.2, encoding a transmembrane glycoprotein: receptor tyrosine kinase.
Drug Insights
4 min read
Deep Scientific Insights on Cangrelor's R&D Progress, Mechanism of Action, and Drug Target
3 October 2023
This article summarized the latest R&D progress of Cangrelor, the Mechanism of Action for Cangrelor, and the drug target R&D trends for Cangrelor.
Latest Hotspot
3 min read
AcuraStem confirms licensing contract with Takeda to progress PIKFYVE treatment methods
3 October 2023
AcuraStem proclaimed it has signed a licensing deal with Takeda.
Drug Insights
4 min read
An In-depth Analysis of Calcifediol's R&D Progress and Mechanism of Action on Drug Target
3 October 2023
This article summarized the latest R&D progress of Calcifediol, the Mechanism of Action for Calcifediol, and the drug target R&D trends for Calcifediol.
Valuable Targets
6 min read
New drugs in the field of diabetes - SGLT1 Inhibitors
3 October 2023
SGLT1, or sodium-glucose co-transporter 1, plays a crucial role in the human body by facilitating the absorption of glucose and galactose in the small intestine.
Drug Insights
4 min read
Folinic acid: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
3 October 2023
This article summarized the latest R&D progress of Folinic acid, the Mechanism of Action for Folinic acid, and the drug target R&D trends for Folinic acid.
Latest Hotspot
3 min read
Alvotech reveals Japan’s authorization of AVT04 (ustekinumab), a biosimilar counterpart to Stelara®
3 October 2023
Alvotech revealed that its distribution associate in Japan, Fuji Pharma Co., Ltd., has obtained commercialisation authorization for AVT04 (ustekinumab).